Curis
CRIS
#11166
Rank
$2.01 M
Marketcap
$0.83
Share price
-0.99%
Change (1 day)
-50.26%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -$14.22

According to Curis's latest financial reports the company's current EPS (TTM) is -$14.22. In 2025 the company made an earnings per share (EPS) of -$23.81 an increase over its 2024 EPS that were of -$140.60.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$14.22-40.28%
2025-$23.81-83.07%
2024-$140.60-22.15%
2023-$180.60-26.17%
2022-$244.6022.3%
2021-$200.00-25.37%
2020-$268.00-30.93%
2019-$388.00-2.02%
2018-$396.00
2016-$900.00-10%
2015-$1,000.00138.1%
2014-$420.0040%
2013-$300.00-25%
2012-$400.0066.67%
2011-$240.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.76-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.54-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-$0.36-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$3.30-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$4.35-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-$3.18-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-$3.44-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA